Luiz Magno
Luiz André Magno is Executive Director of Medical Affairs at Lilly in Brazil. A physician with a PhD in Health Sciences from USP and a specialist in Health Management from FGV, he has extensive experience in medical leadership, clinical research, and innovation in the pharmaceutical industry, working in Brazil and international markets.
The Pen Everyone Wants: Science, Market, and Control of the Body
Medications originally developed to treat metabolic diseases, such as Mounjaro, have come to occupy a central place in conversations about health, behavior and relationship with the body. The interview proposes to discuss the scientific advancement behind these therapies, their indicated uses, the necessary precautions for responsible adoption and the social, economic and public health impacts that this new generation of medications may generate in the medium and long term.